Gene: Coro1a
Official Full Name: coronin, actin binding protein 1Aprovided by MGI
Gene Summary: This gene encodes a member of the WD repeat coronin family. The encoded protein may bind actin and interact with microtubules. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01144 | Coro1a Knockout cell line(RAW 264.7) | Mouse | Coro1a | 1:2-1:3 | Negative | Online Inquiry |
Coro1a Gene Knockout Cell Lines are genetically engineered cell models designed specifically to study the functions and mechanisms of the Coronin-1A protein in various biological processes. These cell lines have been created using CRISPR-Cas9 technology to disrupt the Coro1a gene, allowing researchers to analyze the resultant phenotypic changes and cellular behaviors in-depth. The knockout of Coro1a leads to significant alterations in cytoskeletal dynamics, immune cell functioning, and apoptosis, making these cell lines invaluable tools for dissecting the complexities of cellular processes and signaling pathways.
The key function of Coro1a involves its role in the regulation of actin dynamics and macrophage phagocytosis, positions it as a critical player in immune responses and cell motility. By employing these knockout cell lines, researchers can effectively glean insights into the role of Coronin-1A in cellular communication, immune activation, and potential disease mechanisms, including autoimmunity and cancer progression.
In terms of scientific importance, these cell lines have wide-ranging applications, extending from fundamental research on cellular morphology to translational studies aimed at developing targeted therapies. Their ability to serve as models for studying immune deficiencies or aberrations in cytoskeletal arrangement makes them particularly relevant in clinical settings, where understanding the role of specific proteins can lead to breakthroughs in treatment approaches.
Coro1a Gene Knockout Cell Lines offer unique advantages over traditional cell models, including precise genetic modifications and the ability to replicate specific disease states more accurately. Unlike conventional methods that may only partially inhibit protein function, these knockout lines completely abrogate Coro1a expression, providing clear results and enabling more robust experimental design.
For researchers and clinicians, the value of utilizing Coro1a Gene Knockout Cell Lines lies not only in their ability to elucidate pathways involved in key physiological processes but also in their potential to contribute to the design of novel therapeutic strategies aimed at modulating immune responses and combating diseases. Our company brings expertise in advanced genetic engineering and cell line development, ensuring that each product meets rigorous scientific standards and supports groundbreaking research in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.